• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22466 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Regorafenib (Stivarga®) in pts with metastatic colorectal cancer (CRC) who have progressed after standard therapy
2022     Agency for Care Effectiveness (ACE) Regorafenib and sunitinib for treating advanced gastrointestinal stromal tumours
2022     Agency for Care Effectiveness (ACE) Regorafenib and trifluridine/tipiracil for previously treated metastatic colorectal cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Regorafenib for metastatic colorectal cancer - third or fourth line
2019     National Institute for Health and Care Excellence (NICE) Regorafenib for previously treated advanced hepatocellular carcinoma. NICE technology appraisal guidance 555
2023     National Institute for Health and Care Excellence (NICE) Regorafenib for previously treated metastatic colorectal cancer. NICE technology appraisal guidance 866
2017     National Institute for Health and Care Excellence (NICE) Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours. NICE technology appraisal guidance 488
2018     Andalusian Health Technology Assessment Area (AETSA) Regorafenib indicated as monotherapy for the treatment of adult patients with hepatocellular carcinoma who have been previously treated with sorafenib. EUnetHTA adopted HTA report.
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Regular health monitoring for older adults: clinical evidence
2022     Austrian Institute for Health Technology Assessment (AIHTA) Regulation and financing of prenatal screening and diagnostic examinations for fetal anomalies in selected European countries
2014     NIHR Health Technology Assessment programme Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2014     NIHR Health Technology Assessment programme Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2021     NIHR Health Services and Delivery Research programme REhabilitation and recovery of peopLE with Aphasia after StrokE (RELEASE): Utilizing secondary data to enhance speech and language therapy interventions for people with aphasia after stroke
2019     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rehabilitation for children and adolescents in Austria: A systematic analysis of evaluation methodologies
2015     NIHR Health Technology Assessment programme Rehabilitation for distal radial fractures in adults
2003     Centre for Clinical Effectiveness (CCE) Rehabilitation for postural deformity in Parkinson's disease
1999     Agency for Healthcare Research and Quality (AHRQ) Rehabilitation for traumatic brain injury
1999     Agency for Healthcare Research and Quality (AHRQ) Rehabilitation for traumatic brain injury in children and adolescents
2009     Norwegian Knowledge Centre for the Health Services (NOKC) Rehabilitation of breast cancer patients
2009     Norwegian Knowledge Centre for the Health Services (NOKC) Rehabilitation of breast cancer patients
1999     New Zealand Health Technology Assessment (NZHTA) Rehabilitation of cerebrovascular disorder (stroke): early discharge and support: a critical appraisal of the literature
2009     NIHR Health Technology Assessment programme Rehabilitation of older patients: day hospital compared to rehabilitation at home. A randomised controlled trial
2010     The Swedish Council on Health Technology Assessment (SBU) Rehabilitation of patients with chronic pain conditions
2010     Adelaide Health Technology Assessment (AHTA) Rehabilitation of stroke patients using virtual reality games
2000     Danish Institute for Health Services Research (DSI) Rehabilitation of the elderly in the municipalities - based on six interviews
2018     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rehabilitation pathways following hip and knee arthroplasty. Final report
2008     HAYES, Inc. Rehabilitation therapy for complex regional pain syndrome (CRPS)/ reflex sympathetic dystrophy (RSD)
2014     Penn Medicine Center for Evidence-based Practice (CEP) Rehydration, anti-diarrheal, and anti-emetic therapy for patients with Ebola virus disease
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Reimbursement processes - an analysis of international practice models for maintaining the health benefit baskets of solidly financed health care systems
2010     NIHR Health Technology Assessment programme Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis
2013     Penn Medicine Center for Evidence-based Practice (CEP) Relationship between hemoglobin A1c levels and complications after elective hip and knee surgery
2024     NIHR Health and Social Care Delivery Program Relationship between staff and quality of care in care homes: StaRQ mixed methods study
2015     Agency for Healthcare Research and Quality (AHRQ) Relationship between use of quality measures and improved outcomes in serious mental illness
1995     University of York Relationship between volume and quality of health care: a review of the literature
2013     Health Quality Ontario (HQO) Relationship of patient volume and stroke outcomes: a rapid review
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Relative benefits of various types of hip prostheses
1998     Agency for Healthcare Research and Quality (AHRQ) Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer
2005     Agency for Healthcare Research and Quality (AHRQ) Relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy: part 1, gefitinib and erlotinib for non-small cell lung cancer
2005     Agency for Healthcare Research and Quality (AHRQ) Relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy: part 2, imatinib for gastrointestinal stromal tumors (GIST)
2005     Agency for Healthcare Research and Quality (AHRQ) Relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy: part 3, imatinib for chronic myeloid leukemia (CML)
2005     Agency for Healthcare Research and Quality (AHRQ) Relative efficacy of oral cancer therapy for Medicare beneficiaries versus currently covered therapy: part 4, thalidomide for multiple myeloma
2016     NIHR Horizon Scanning Centre (NIHR HSC) Relebactam with imipenem and cilastatin - multi-drug resistant or carbapenem resistant Gram-negative infections
2012     Agency for Healthcare Research and Quality (AHRQ) Reliability testing of the AHRQ EPC approach to grading the strength of evidence in comparative effectiveness reviews
2000     Alberta Heritage Foundation for Medical Research (AHFMR) ReliefBand
2008     HAYES, Inc. Relieva balloon sinuplast (Acclarent Inc.) for treatment of chronic sinusitis
2012     HAYES, Inc. Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in adults
2012     HAYES, Inc. Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in children
2011     HAYES, Inc. Relieva balloon sinuplasty (Acclarent Inc.) for treatment of chronic sinusitis
2022     National Institute for Health and Care Excellence (NICE) Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids. NICE technology appraisal guidance 832
2012     NIHR Health Technology Assessment programme REMCARE: reminiscence groups for people with dementia and their family caregivers - effectiveness and cost-effectiveness pragmatic multicentre randomised trial
2020     European Network for Health Technology Assessment (EUnetHTA) Remdesivir for the treatment of COVID-19
2020     Penn Medicine Center for Evidence-based Practice (CEP) Remdesivir for treatment of COVID-19 disease
2020     European Network for Health Technology Assessment (EUnetHTA) Remdesivir or the treatment of COVID-19. PICO and evidence gaps
2015     NIHR Horizon Scanning Centre (NIHR HSC) Remestemcel-L (Prochymal) for steroid refractory acute graft versus host disease – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Remestemcel-L for graft vs host disease in paediatric patients – second line
2011     HAYES, Inc. Remicade (Infliximab; Janssen Biotech Inc., a Johnson&Johnson Company) for treatment of neurosarcoidosis
2011     HAYES, Inc. Remicade (Infliximab; Janssen Biotech Inc., a Johnson&Johnson Company) for treatment of pulmonary sarcoidosis
2013     HAYES, Inc. Remicade (infliximab; Janssen Biotech Inc.) for first-line treatment of pediatric crohn's disease
2006     NIHR Horizon Scanning Centre (NIHR HSC) Remiplistim (AMG 531) for idiopathic thrombocytopenic purpura: horizon scanning technology note
2007     Agency for Healthcare Research and Quality (AHRQ) Remote cardiac monitoring
2012     HAYES, Inc. Remote cognitive-behavioral therapy for bulimia nervosa
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Remote ischemic conditioning: a review of the clinical effectiveness
2008     Adelaide Health Technology Assessment (AHTA) Remote monitoring for implantable cardiac devices
2023     NIHR Health Services and Delivery Research programme Remote monitoring for long-term physical health conditions: an evidence and gap map
2010     Belgian Health Care Knowledge Centre (KCE) Remote monitoring for patients with implanted defibrillators. Technology evaluation and broader regulatory framework
2020     Health Technology Wales (HTW) Remote monitoring of blood glucose in women with gestational diabetes
2003     NIHR Horizon Scanning Centre (NIHR HSC) Remote monitoring of implantable cardiac devices - horizon scanning review
2006     NIHR Horizon Scanning Centre (NIHR HSC) Remote monitoring of implantable cardiac devices for cardiac arrhythmia - horizon scanning review
2018     Health Quality Ontario (HQO) Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment
2021     Belgian Health Care Knowledge Centre (KCE) Remote monitoring of patients with cardiovascular implantable electronic devices: a health technology assessment (update of the KCE Report 136)
2008     HAYES, Inc. Remote monitoring of patients with congestive heart failure
2014     Medical Services Advisory Committee (MSAC) Remote monitoring of patients with implanted cardiac devices
2014     Medical Services Advisory Committee (MSAC) Remote monitoring of patients with implanted cardiac devices (resubmission)
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Remote monitoring programs for cardiac conditions
2006     Adelaide Health Technology Assessment (AHTA) Remote monitoring systems for implantable cardiac devices (cardioverter defibrillators andpacemakers)
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2014     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2010     Adelaide Health Technology Assessment (AHTA) Remote-controlled catheter navigation systems
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Removable rigid dressings for leg amputation: a review of the clinical effectiveness, cost effectiveness and guidelines
2010     The Regional Health Technology Assessment Centre (HTA-centrum) Removal of impacted wisdom teeth
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Removal of intravenous lines following outpatient day procedures: guidelines
2019     Swiss Federal Office of Public Health (FOPH) Removal of osteosynthesis materials (e.g. screws, plates, nails and wires) used to treat bone fractures
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Removal of physical restraints in long term care settings: clinical safety and harm
2012     Agenzia nazionale per i servizi sanitari regionali (Agenas) Renal artery ablation in patients with treatment-resistant hypertension: a systematic review
2016     Agency for Healthcare Research and Quality (AHRQ) Renal artery stenosis management strategies: an updated comparative effectiveness review
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Renal denervation
2013     New Zealand National Health Committee (NHC) Renal denervation – technology note
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Renal denervation for resistant hypertension
2024     Penn Medicine Center for Evidence-based Practice (CEP) Renal denervation for treatment of resistant hypertension
2016     Agency for Healthcare Research and Quality (AHRQ) Renal denervation in the Medicare Population
2023     Health Technology Wales (HTW) Renal denervation to treat people with resistant hypertension
2006     HAYES, Inc. Renal stenting for treatment of renal stenosis in patients with hypertension
2010     Adelaide Health Technology Assessment (AHTA) Renal sympathetic denervation for the treatment of resistant hypertension
2013     The Regional Health Technology Assessment Centre (HTA-centrum) Renal sympathetic denervation in patients with therapy resistant hypertension
1997     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Renal-pancreatic transplantation - primary research
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for advanced or metastatic pancreatic cancer – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reolysin for relapsed or refractory multiple myeloma
2015     NIHR Health Services and Delivery Research programme Reorganising specialist cancer surgery for the 21st century: a mixed methods evaluation (RESPECT-21)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reparixin for prevention of delayed graft function in pancreatic islet transplantation for type 1 diabetes mellitus
2023     Health Information and Quality Authority (HIQA) Repatriation of paediatric haematopoietic stem cell transplant services to Ireland: a Health Technology Assessment